Patents by Inventor Naoko Matsuura

Naoko Matsuura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9711815
    Abstract: An object of the invention is to provide a fuel cell having improved long-term durability. The patent provides a fuel cell comprising a peroxide decomposition catalyst immobilized on a support, wherein the fuel cell is constituted of a membrane electrode assembly comprising a polyelectrolyte membrane, electrode layers placed on both the sides of the electrolyte membrane, and gas diffusion layers placed on the side opposite to the electrolyte membrane of the electrode layers, a gas sealing material placed surrounding the membrane electrode assembly, and separators sandwiching the foregoing.
    Type: Grant
    Filed: October 5, 2011
    Date of Patent: July 18, 2017
    Assignee: W. L. Gore & Associates, Co., Ltd.
    Inventors: Tomoyuki Takane, Naoko Matsuura
  • Publication number: 20130330649
    Abstract: An object of the invention is to provide a fuel cell having improved long-term durability. The patent provides a fuel cell comprising a peroxide decomposition catalyst immobilized on a support, wherein the fuel cell is constituted of a membrane electrode assembly comprising a polyelectrolyte membrane, electrode layers placed on both the sides of the electrolyte membrane, and gas diffusion layers placed on the side opposite to the electrolyte membrane of the electrode layers, a gas sealing material placed surrounding the membrane electrode assembly, and separators sandwiching the foregoing.
    Type: Application
    Filed: October 5, 2011
    Publication date: December 12, 2013
    Applicant: W.L. Gore & Associates, Co. Ltd.
    Inventors: Tomoyuki Takane, Naoko Matsuura
  • Patent number: 8431589
    Abstract: There are provided compounds of formula I wherein X, R1, R2, R3, R4, R5, R6, R7, R8 and R9 are as indicated in claim 1 , useful in disorders where ZAP-70 and/or Syk inhibition plays a role or caused by a malfunction of signal cascades connected with FAK.
    Type: Grant
    Filed: March 23, 2011
    Date of Patent: April 30, 2013
    Assignee: Novartis AG
    Inventors: Rolf Baenteli, Gerhard Zenke, Nigel Graham Cooke, Rudolf Duthaler, Gebhard Thoma, Anette Von Matt, Toshiyuki Honda, Naoko Matsuura, Kazuhiko Nonomura, Osamu Ohmori, Ichiro Umemura, Klaus Hinterding, Christos Papageorgiou
  • Patent number: 8410275
    Abstract: The present invention relates to novel compounds of formula (I) or a pharmaceutical composition thereof, with all the variables being defined in the text. The present invention further relates to the use of the compounds herein for treatment of or delay progression to overt to diseases in which CETP is involved.
    Type: Grant
    Filed: May 17, 2012
    Date of Patent: April 2, 2013
    Assignee: Novartis AG
    Inventors: Masashi Kishida, Naoko Matsuura, Hidetomo Imase, Yuki Iwaki, Ichiro Umemura, Osamu Ohmori, Eiji Kawahara
  • Patent number: 8263590
    Abstract: Novel pyrimidine derivatives of formula I to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them.
    Type: Grant
    Filed: April 27, 2011
    Date of Patent: September 11, 2012
    Inventors: Carlos Garcia-Echeverria, Takanori Kanazawa, Eiji Kawahara, Keiichi Masuya, Naoko Matsuura, Takahiro Miyake, Osamu Ohmori, Ichiro Umemura
  • Publication number: 20120225874
    Abstract: The present invention relates to novel compounds of formula (I) or a pharmaceutical composition thereof, with all the variables being defined in the text. The present invention further relates to the use of the compounds herein for treatment of or delay progression to overt to diseases in which CETP is involved.
    Type: Application
    Filed: May 17, 2012
    Publication date: September 6, 2012
    Applicant: NOVARTIS AG
    Inventors: Masashi KISHIDA, Naoko MATSUURA, Hidetomo IMASE, Yuki IWAKI, Ichiro UMEMURA, Osamu OHMORI, Eiji KAWAHARA
  • Patent number: 8232403
    Abstract: The present invention relates to novel compounds of formula (I) or a pharmaceutical composition thereof, with all the variables being defined in the text. The present invention further relates to the use of the compounds herein for treatment of or delay progression to overt to diseases in which CETP is involved.
    Type: Grant
    Filed: May 8, 2007
    Date of Patent: July 31, 2012
    Assignee: Novartis AG
    Inventors: Masashi Kishida, Naoko Matsuura, Hidetomo Imase, Yuki Iwaki, Ichiro Umemura, Osamu Ohmori, Eiji Kawahara
  • Publication number: 20110201606
    Abstract: Novel pyrimidine derivatives of formula I to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them
    Type: Application
    Filed: April 27, 2011
    Publication date: August 18, 2011
    Applicant: Novartis AG
    Inventors: Carlos Garcia-Echeverria, Takanori Kanazawa, Eiji Kawahara, Keiichi Masuya, Naoko Matsuura, Takahiro Miyake, Osamu Ohmori, Ichiro Umemura
  • Publication number: 20110172231
    Abstract: There are provided compounds of formula I wherein X, R1, R2, R3, R4, R5, R6, R7, R8 and R9 are as indicated in claim 1, useful in disorders where ZAP-70 and/or Syk inhibition plays a role or caused by a malfunction of signal cascades connected with FAK.
    Type: Application
    Filed: March 23, 2011
    Publication date: July 14, 2011
    Inventors: Rolf BAENTELI, Gerhard Zenke, Nigel Graham Cooke, Rudolf Duthaler, Gebhard Thoma, Anette Von Matt, Toshiyuki Honda, Naoko Matsuura, Kazuhiko Nonomura, Osamu Ohmori, Ichiro Umemura, Klaus Hinterding, Christos Papageorgiou
  • Patent number: 7964592
    Abstract: Novel pyrimidine derivatives of formula I to process for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them.
    Type: Grant
    Filed: March 12, 2004
    Date of Patent: June 21, 2011
    Assignee: Novartis AG
    Inventors: Carlos Garcia-Echeverria, Takanori Kanazawa, Eiji Kawahara, Keiichi Masuya, Naoko Matsuura, Takahiro Miyake, Osamu Ohmori, Ichiro Umemura
  • Patent number: 7943627
    Abstract: There are provided compounds of formula I wherein X, R1, R2, R3, R4, R5, R6, R7, R8 and R9 are as indicated in claim 1, useful in disorders where ZAP-70 and/or Syk inhibition plays a role or caused by a malfunction of signal cascades connected with FAK.
    Type: Grant
    Filed: March 14, 2003
    Date of Patent: May 17, 2011
    Assignee: Novartis AG
    Inventors: Rolf Baenteli, Gerhard Zenke, Nigel Graham Cooke, Rudolf Duthaler, Gebhard Thoma, Anette Von Matt, Toshiyuki Honda, Naoko Matsuura, Kazuhiko Nonomura, Osamu Ohmori, Ichiro Umemura, Klaus Hinterding, Christos Papageorgiou
  • Publication number: 20110098280
    Abstract: Novel pyrimidine derivatives of formula I to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them.
    Type: Application
    Filed: January 4, 2011
    Publication date: April 28, 2011
    Applicants: Novartis AG, IRM LLC
    Inventors: Carlos Garcia-Echeverria, Takanori Kanazawa, Eiji Kawahara, Keiichi Masuya, Naoko Matsuura, Takahiro Miyake, Osamu Ohmori, Ichiro Umemura, Ruo Steensma, Greg Chopiuk, Jiqing Jiang, Yongqin Wan, Qiang Ding, Qiong Zhang, Nathanael Schiander Gray, Donald Karanewsky
  • Patent number: 7893074
    Abstract: Novel pyrimidine derivatives of formula I to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them.
    Type: Grant
    Filed: August 13, 2004
    Date of Patent: February 22, 2011
    Assignees: Novartis AG, IRM LLC
    Inventors: Carlos Garcia-Echeverria, Takanori Kanazawa, Eiji Kawahara, Keiichi Masuya, Naoko Matsuura, Takahiro Miyake, Osamu Ohmori, Ichiro Umemura, Ruo Steensma, Greg Chopiuk, Jiqing Jiang, Yongqin Wan, Qiang Ding, Qiong Zhang, Nathanael Schiander Gray, Donald Karanewsky
  • Publication number: 20090227580
    Abstract: The present invention relates to novel compounds of formula (I) or a pharmaceutical composition thereof, with all the variables being defined in the text. The present invention further relates to the use of the compounds herein for treatment of or delay progression to overt to diseases in which CETP is involved.
    Type: Application
    Filed: May 8, 2007
    Publication date: September 10, 2009
    Inventors: Masashi Kishida, Naoko Matsuura, Hidetomo Imase, Yuki Iwaki, Ichiro Umemura, Osamu Ohmori, Eiji Kawahara
  • Publication number: 20090131436
    Abstract: Novel pyrimidine derivatives of formula (I) to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them.
    Type: Application
    Filed: August 26, 2005
    Publication date: May 21, 2009
    Inventors: Patricia Imbach, Eiji Kawahara, Kazuhide Konishi, Naoko Matsuura, Takahiro Miyake, Osamu Ohmori, Johannes Roesel, Naoki Teno, Ichiro Umemura
  • Publication number: 20090075968
    Abstract: The present invention relates to a compound of formula or a pharmaceutically acceptable salt thereof, wherein the variables are as defined.
    Type: Application
    Filed: December 27, 2006
    Publication date: March 19, 2009
    Inventors: Junichi Sakaki, Masashi Kishida, Naoko Matsuura, Ichiro Umemura, Eiji Kawahara, Ken Yamada, Kazuhide Konishi, Yuki Iwaki, Hidetomo Imase, Takahiro Miyake
  • Publication number: 20080132504
    Abstract: Novel pyrimidine derivatives of formula I to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them
    Type: Application
    Filed: August 13, 2004
    Publication date: June 5, 2008
    Inventors: Carlos Garcia-Echeverria, Takanori Kanazawa, Eiji Kawahara, Keiichi Masuya, Naoko Matsuura, Takahiro Miyake, Osamu Ohmori, Ichiro Umemura, Ruo Steensma, Greg Chopiuk, Jiqing Jiang, Yongqin Wan, Qiang Ding, Qiong Zhang, Nathanael Schiander Gray, Donald Karanewsky
  • Publication number: 20060247241
    Abstract: Novel pyrimidine derivatives of formula I to process for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them
    Type: Application
    Filed: March 12, 2004
    Publication date: November 2, 2006
    Inventors: Carlos Garcia-Echeverria, Takanori Kanazawa, Eiji Kawahara, Keiichi Masuya, Naoko Matsuura, Takahiro Miytake, Osamu Ohmori, Ichiro Umemura
  • Publication number: 20060100227
    Abstract: There are provided compounds of formula I Wherein X, R1, R2, R3, R4, R5, R6, R7, R8 and R9 are as indicated in claim 1, useful in disorders where ZAP-70 and/or Syk inhibition plays a role or caused by a malfunction of signal cascades connected with FAK.
    Type: Application
    Filed: March 14, 2003
    Publication date: May 11, 2006
    Inventors: Rolf Baenteli, Gerhard Zenke, Nigel Cooke, Rudolf Duthaler, Gebhard Thoma, Anette Von Matt, Toshiyuki Honda, Naoko Matsuura, Kazuhiko Nonomura, Osamu Ohmori, Ichiro Umemura, Klaus Hinterding, Christos Papageorgiou
  • Patent number: 5202151
    Abstract: The present invention relates to an electroless gold plating solution, a method of plating by using the same, and an electronic device plated with gold by using the same.According to the present electroless gold plating solution, the plating solution components contain no cyanide ions, the amount of a reducing agent used is small, and gold plating can be carried out without causing the gold plating on conducting paths having a fine interval between them to short-circuit the conducting paths.Therefore, according to the method of gold plating by using said electroless gold plating solution, a plating method that is safe in the plating work and in the treatment of its waste liquor can be accomplished. The method has a feature that the method can provide an electronic device on which parts can be mounted highly densely, and wherein the joint reliability to the parts is high.
    Type: Grant
    Filed: June 4, 1990
    Date of Patent: April 13, 1993
    Assignee: Hitachi, Ltd.
    Inventors: Jiro Ushio, Osamu Miyazawa, Akira Tomizawa, Hitoshi Yokono, Naoya Kanda, Naoko Matsuura, Setsuo Ando, Hiroaki Okudaira